Search for Clinical Trial Results
Acute Erythroid Leukemia - 189 Studies Found
Status | Study |
Recruiting |
Study Name: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy Condition:
|
Active, not recruiting |
Study Name: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay Condition:
|
Active, not recruiting |
Study Name: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML Condition:
|
Active, not recruiting |
Study Name: Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia Condition:
Interventions: |
Withdrawn |
Study Name: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Condition:
|